DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

97.80 0.55 (0.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $97.80 0.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $96.00
Previous Close $97.25
Daily Range $94.30 - $99.41
52-Week Range $63.48 - $140.00
Market Cap $8.3B
P/E Ratio -44.00
Dividend (Yield) $0.00 (0.0%)
Volume 431,956
Average Daily Volume 792,384
Current FY EPS -$3.17

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary

PCSK9 Drugs Are Here (and Way Over There)

As the first generation of the cholesterol-lowering drugs hits the market, investors should already be looking at the next-generation products.

The Zacks Analyst Blog Highlights: Amgen, ARIAD, Celgene, Amicus and Alnylam

Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?

Alnylam Pharmaceuticals (ALNY) Falls: Stock Goes Down 5.7%

Premarket Biotech Digest: Natural Killer Cells, Lipocine NDA, FDA Calendar

Alnylam Presents Positive Data on PCSK9 Synthesis Inhibitor

Biotech Review (Part 2 Of 3): New Coverage Of Some Mid-Caps With Update On Intercept

Why The Medicines Company's Stock Broke Out Today

A positive clinical update for an experimental cholesterol treatment sent shares of The Medicines Co. higher today.

First Week of October 16th Options Trading For Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY) Stock: Weak On High Volume Today

See More ALNY News...

ALNY's Top Competitors

ALNY $97.80 (0.57%)
Current stock: ALNY
AMGN $147.02 (-1.48%)
Current stock: AMGN
GILD $102.06 (0.15%)
Current stock: GILD
BIIB $302.26 (0.21%)
Current stock: BIIB